NIH-funded research R01 grant

AI-enhanced wide-field eye scans for detecting retinopathy of prematurity

Official title: Artificial Intelligence Assisted Panoramic Optical Coherence Tomography Angiography for Retinopathy of Prematurity

Funded at Oregon Health & Science University · NIH-11381770 · Data updated 2026-11-12

Using faster handheld wide-field eye scans plus AI to find early signs of retinopathy of prematurity in premature babies and help guide treatment.

More Prematurity research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOregon Health & Science University
NIH-funded
Lab location1 site (Portland, United States)
Project startJuly 1, 2020
Project endApril 30, 2030
Funding year2026
Award (this year)$657,651
NIH project number5R01HD107494-06
Project IDNIH-11381770 on NIH RePORTER

Who could benefit from this research

Could help

Premature infants who meet standard ROP screening criteria and are receiving care in neonatal intensive care units are the ideal candidates.

Less likely to help

Full-term infants without ROP risk or infants with already extensive, irreversible retinal detachment are unlikely to benefit from this work.

What this research studies

If your baby was born prematurely and is at risk for retinopathy of prematurity, this project uses newly developed faster, wide-field handheld OCT and OCTA scanners to take detailed images of the infant's retina. An artificial-intelligence tool helps read those images to reduce examiner differences and detect disease features earlier than the traditional eye exam. The research team has built prototypes and collected thousands of neonatal eye images to improve the scans and the AI. The aim is to make screening more objective so fewer babies are under-treated or over-treated.

Why it matters

Potential benefit: This could enable earlier, more objective detection and treatment of ROP, lowering the risk of preventable retinal detachment and vision loss.

How similar studies have gone: OCT, OCTA, and AI approaches have improved early detection in adult retinal diseases such as diabetic retinopathy, but using wide-field handheld OCTA with AI in neonatal ROP is a newer and less-tested application.

Where this research is happening

  • Oregon Health & Science University
    Portland, United States
    Active

Researchers

  • Principal investigator: Jian, Yifan — Oregon Health & Science University
  • Study coordinator: Jian, Yifan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.